Oxford Spin-out Equity Management Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
132
- Portfolio
-
41
- Exits
-
83
Oxford Spin-out Equity Management General Information
Description
Founded in 1988, Oxford Spin-out Equity Management is a venture capital firm based in Oxford, United Kingdom. The firm manages Oxford University's shareholdings in its spin-out companies and seeks ways of maximizing the value of its equity stakes.
Contact Information
Website
www.osem.ox.ac.uk
Year Founded
1998
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Buxton Court
- 3 West Way, Botley
- Oxford OX2 0JB
- England, United Kingdom
+44 01865 000000
Oxford Spin-out Equity Management Investments (132)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| OMass Therapeutics | 19-Apr-2022 | Later Stage VC | 00000 | Drug Discovery | Pre-Clinical Trials | |
| 000 | 08-May-2020 | 00000 00000 | 0000 | Educational Software | Generating Revenue | |
| 0000000 | 20-Mar-2020 | 00000 00000 | 000.00 | Enterprise Systems (Healthcare) | Generating Revenue | |
| 00000000 | 04-Jun-2019 | 0000 00000 | 00.000 | Diagnostic Equipment | Generating Revenue | |
| 00000 000000000 (0 | 05-Oct-2018 | 00000 00000 | 000 | Discovery Tools (Healthcare) | Generating Revenue | 00000 000000000 |
| 0000 000000000000 | 03-Sep-2018 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | |
| 00000 | 01-Jan-2018 | 00000 00000 | Electronic Equipment and Instruments | Generating Revenue | ||
| 0000000 (000000000 | 30-Jun-2017 | 0000 00000 | 00000 | Household Appliances | Generating Revenue | |
| Zegami | 26-Jun-2017 | Early Stage VC | 00.000 | Business/Productivity Software | Generating Revenue | |
| Celleron Therapeutics | 31-Jan-2017 | Later Stage VC | 000.00 | Biotechnology | Clinical Trials - Phase 2 |
Oxford Spin-out Equity Management Exits (83)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Argonaut Therapeutics | 05-Jan-2023 | Merger/Acquisition | |
| 000000 | 08-Aug-2022 | 0000000000: 000000 | |
| 00000 000000000000 | 27-May-2022 | 0000000000: 000000 | |
| 000000 0000 | 01-Nov-2021 | 000000000 00000000 | |
| 000000 00000000 00 | 30-Sep-2021 | 000 | 00000 |
| 0000 | 01-Sep-2021 | 000000000 00000000 | |
| 0000 | 22-Jul-2021 | 000000000000000000 | |
| 0000 00000 | 01-May-2021 | 000000000000000000 | |
| Vaccitech | 30-Apr-2021 | IPO | 00000 |
| Oxford Biomaterials | 01-Apr-2021 | Secondary Transaction - Private |
Oxford Spin-out Equity Management Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Oxford Spin-out Equity Management Team (4)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Jaz Jandor | Office Manager | 0 | Oxford, United Kingdom | ||
| James Mallinson | Director | 00 | 0 | Oxford, United Kingdom |
Oxford Spin-out Equity Management Co-Investors (19)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Oxford Science Enterprises | 3 | 0 |
|
|
|
| GV | 0 | 0 |
|
|
|
| Hostplus Superannuation Fund | 0 |
|
|
||
| IP Group | 0 | 0 |
|
|
|
| Madrona Venture Group | 0 | 0 |
|
|